S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Asian shares mixed after last week's gains on Wall Street
LON:SAR

Sareum - SAR Share Forecast, Price & News

GBX 100
-5.00 (-4.76%)
(As of 01/27/2023 07:40 PM ET)
Add
Compare
Today's Range
98.10
▼
108.50
50-Day Range
70
▼
117.50
52-Week Range
55.10
▼
345
Volume
80,883 shs
Average Volume
125,420 shs
Market Capitalization
£68.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SAR stock logo

About Sareum (LON:SAR) Stock

Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom.

Receive SAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sareum and its competitors with MarketBeat's FREE daily newsletter.

SAR Stock News Headlines

January 23, 2023 | marketwatch.com
NON RECEPTOR TYROSINE PROTEIN KINASE TYK2 Market Evolution Segmentation and Insight of Trends 2023 to 2028 with Top Countries Data
October 25, 2022 | finance.yahoo.com
Sareum Holdings (LON:SAR) Is In A Good Position To Deliver On Growth Plans
January 30, 2023 | Porter & Company (Ad)
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
October 14, 2022 | msn.com
SMALL CAP MOVERS: Property lender Lendinvest sinks 36% to a new low of 64p over risk of falling property prices; Cybersecurity firm Intercede surges 39% - msnNOW
October 13, 2022 | lse.co.uk
Glaxosmithkline News Headlines. GSK Share News. Financial News Articles for Gsk Plc Ord 31 1/4P updated throughout the day. - London South East
October 12, 2022 | lse.co.uk
Nigeria's Forcados crude loadings to restart by end of October - SPDC | Financial News - London South East
October 12, 2022 | marketwatch.com
Sareum Holdings Says Sierra Oncology To Return Cancer Treatment License; Shares Fall - MarketWatch
September 13, 2022 | proactiveinvestors.com.au
Small Cap Feast - Critical Metals, Nightcap, Sareum Holdings, Spectra Systems, Altona Rare Earths and more... - Proactive Investors Australia
January 30, 2023 | Porter & Company (Ad)
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
September 13, 2022 | morningstar.co.uk
CORRECT: Sareum notes US FDA approval of Bristol-Myers's Sotyktu - Morningstar
September 12, 2022 | morningstar.co.uk
Sareum receives US US Food & Drug Administration approval for Sotyktu - Morningstar
July 28, 2022 | globenewswire.com
Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update - GlobeNewswire
July 28, 2022 | finance.yahoo.com
Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update
July 12, 2022 | fool.co.uk
Is the falling Sareum Holdings share price an exciting opportunity? - Motley Fool UK
July 11, 2022 | fool.co.uk
The Sareum Holdings share price is down 47%! Is now the time to buy?
July 4, 2022 | lse.co.uk
Sareum News Headlines. SAR Share News. Financial News Articles for Sareum Holdings Plc Ord Gbp 0.0125 updated throughout the day. - London South East
July 4, 2022 | morningstar.co.uk
IN BRIEF: Sareum notes updated payment terms after GSK buy of SRA737 - Morningstar
July 4, 2022 | morningstar.com
Pound Unable to Benefit From Rate Rises Due to Poor UK Outlook - Morningstar
July 4, 2022 | morningstar.com
FTSE 100 Led Higher by Energy Stocks as Oil Prices Rise - Morningstar
July 4, 2022 | morningstar.com
FTSE 100 to Open Higher But Gains Seen Fragile - Morningstar
July 4, 2022 | marketwatch.com
Sareum Holdings Says GSK Completes Acquisition of Sierra Oncology - MarketWatch
June 10, 2022 | streetinsider.com
Form 6-K Midatech Pharma Plc For: Jun 10 - StreetInsider.com
June 10, 2022 | streetinsider.com
Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman - StreetInsider.com
June 10, 2022 | finance.yahoo.com
Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman - Yahoo Finance
April 25, 2022 | finance.yahoo.com
Companies Like Sareum Holdings (LON:SAR) Are In A Position To Invest In Growth
April 13, 2022 | morningstar.co.uk
TRADING UPDATES: Sureserve gets new CFO; Sareum notes GSK buys Sierra - Morningstar
April 13, 2022 | marketwatch.com
Sareum Holdings Notes Glaxo Purchase of Treatment License Holder Sierra Oncology - MarketWatch
See More Headlines
Receive SAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sareum and its competitors with MarketBeat's FREE daily newsletter.

SAR Company Calendar

Today
1/29/2023
Next Earnings (Estimated)
2/20/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:SAR
CUSIP
N/A
CIK
N/A
Web
www.sareum.co.uk
Phone
+44-1223-497700
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.46
Quick Ratio
10.37

Sales & Book Value

Annual Sales
£47,204.00
Price / Sales
1,442.02
Cash Flow
GBX 8.83 per share
Price / Cash Flow
11.32
Book Value
GBX 6.40 per share
Price / Book
15.63

Miscellaneous

Outstanding Shares
68,069,000
Free Float
N/A
Market Cap
£68.07 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Tim J. Mitchell Ph.D. (Age 63)
    Founder, CEO & Exec. Director
    Comp: $189.6k
  • Dr. John C. Reader Ph.D. (Age 56)
    Founder, Chief Scientific Officer & Exec. Director
    Comp: $187.14k
  • Alexandra Harrison
    Head of IR
  • Mr. Anthony Bunn F.C.M.A.
    FCMA, Sec.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions













SAR Stock - Frequently Asked Questions

How have SAR shares performed in 2023?

Sareum's stock was trading at GBX 82.50 on January 1st, 2023. Since then, SAR shares have increased by 21.2% and is now trading at GBX 100.
View the best growth stocks for 2023 here.

When is Sareum's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 20th 2023.
View our SAR earnings forecast.

What other stocks do shareholders of Sareum own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sareum investors own include ReNeuron Group (RENE), ValiRx (VAL), Sierra Oncology (SRRA), Egdon Resources (EDR), Collagen Solutions plc (COS.L) (COS), Gulf Keystone Petroleum (GKP), Madagascar Oil (MOIL), Summit Therapeutics (SMMT), Rockhopper Exploration (RKH) and

What is Sareum's stock symbol?

Sareum trades on the London Stock Exchange (LON) under the ticker symbol "SAR."

How do I buy shares of Sareum?

Shares of SAR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Sareum's stock price today?

One share of SAR stock can currently be purchased for approximately GBX 100.

How much money does Sareum make?

Sareum (LON:SAR) has a market capitalization of £68.07 million and generates £47,204.00 in revenue each year.

How can I contact Sareum?

Sareum's mailing address is Unit 2A Langford Arch, London Road, Pampisford, CAMBRIDGE, CB22 3FX, United Kingdom. The official website for the company is www.sareum.co.uk. The company can be reached via phone at +44-1223-497700.

This page (LON:SAR) was last updated on 1/30/2023 by MarketBeat.com Staff